Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

363 results
  1. ... PubMed : 23206845 ] Nunes NS, Kanakry CG: Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding. Front ...
  2. ... O, Herscovici C, et al.: Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a ...
  3. NLM Digital Collections - Antilymphocyte serum mode of action and clinical applicability 
    Publication: Fort Sam Houston, Tex. : The Academy, [1975]
    ... investigated in the prevention of graft rejection and prevention of graft versus host disease and lymphocyte serum. As many of you know, ...
  4. NLM Digital Collections - FDA oversight 
    Publication: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
    ... the FDA approved Orencia (abatacept) for the prophylaxis (prevention) of acute graft versus host disease (aGVHD), a condition that occurs when donor bone ...
  5. NLM Digital Collections - Manufacture of blood components using a pathogen reduction device in blood establishments : ... 
    Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, November 2021
    ... used as an alternative to gamma irradiation for prevention of transfusion-associated graft versus host disease (TA-GVHD). 2 Contains Nonbinding Recommendations 5. Can ...
  6. ... about the prevention of acute GVHD, see the Prevention and treatment of acute GVHD section in Complications, Graft-Versus-Host Disease, and Late Effects After Pediatric Hematopoietic Stem Cell ...
  7. ... quality of life, early and late toxicity including graft-versus-host-disease (GvHD) and resource use. This research should be included as an option in appropriate mainstream clinical trials for myeloma. 5. Bisphosphonates for the prevention of bone disease What is the effectiveness of ...
  8. ... of non-bacterial infection Investigation and management of graft versus host ... Main outcomes Mortality rate. ...
  9. ... tw. exp Peripheral Blood Stem Cell Transplantation/ exp Graft vs Host Disease/ exp Bone Marrow Purging/ exp Bone Marrow/ Bone Marrow.tw. exp Vincristine/ exp Neoplasm Recurrence, Local/pc [Prevention & Control] exp Salvage Therapy/ high-dose therapy.tw. ( ...
  10. ... whether fish oil supplementation could benefit treatment or prevention of IgA nephropathy following transplantation. Additional studies in bone marrow transplantation where a benefit on acute colonic graft versus host disease and a survival benefit have been suggested. Long‐ ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last